Viewing Study NCT02720367


Ignite Creation Date: 2025-12-25 @ 12:34 AM
Ignite Modification Date: 2026-03-02 @ 10:04 PM
Study NCT ID: NCT02720367
Status: COMPLETED
Last Update Posted: 2020-03-10
First Post: 2016-02-25
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Safety and Tolerability of TAR-200 mg in Subjects With Non-Muscle-Invasive Bladder Cancer
Sponsor: Taris Biomedical LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module